Pharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide.

about

Synthesis and antiproliferative activity of glutamic acid-based dipeptides.Natural compounds for pediatric cancer treatment.Characterization and antitumor efficacy of poly(L-lactid acid)-based etoposide-loaded implants.

P2860

Q35611178-FD353D22-EEE6-4C31-B9A1-74028DB17688 Q38663897-34C9BC51-EE80-44CF-9A04-53EA88091B22 Q50887645-70B33571-00D1-41C5-946B-2459280D8BF6

P2860

Pharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide.

Item

http://www.wikidata.org/entity/Q38185496

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmaceutical and pharmacolog ...... lity enhancement of etoposide.

@en

type

Item

label

Pharmaceutical and pharmacolog ...... lity enhancement of etoposide.

@en

prefLabel

Pharmaceutical and pharmacolog ...... lity enhancement of etoposide.

@en

P1476

Pharmaceutical and pharmacolog ...... lity enhancement of etoposide.

@en

P2093

Ishtiyaq Ahmad Najar

http://www.w3.org/2001/XMLSchema#string

Rakesh Kamal Johri

http://www.w3.org/2001/XMLSchema#string

P2860

Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation

Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.

Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs.

Laminin receptor-targeted etoposide loaded polymeric micelles: a novel approach for the effective treatment of tumor metastasis.

Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.

Pharmacologic modulation strategies to reduce dose requirements of anticancer therapy while preserving clinical efficacy.

Colloidal formulations of etoposide based on poly(butyl cyanoacrylate) nanoparticles: preparation, physicochemical properties and cytotoxicity.

Reformulation of etoposide with solubility-enhancing rubusoside.

Liposomal formulations of Etoposide and Docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines.

Intracellular delivery of etoposide loaded biodegradable nanoparticles: cytotoxicity and cellular uptake studies.

P2888

s12038-013-9399-3

P304

139-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12038-013-9399-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010242645

http://www.w3.org/2001/XMLSchema#string

P698

24499798

http://www.w3.org/2001/XMLSchema#string

Pharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide.

about

P2860

P2860

Pharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698